Literature DB >> 19674504

Low-affinity Fcgamma receptors, autoimmunity and infection.

Lisa C Willcocks1, Kenneth G C Smith, Menna R Clatworthy.   

Abstract

Low-affinity Fcgamma receptors (FcgammaRs) mediate the effects of immunoglobulin G (IgG) antibodies on leukocytes, including recruitment to inflammatory lesions, phagocytosis, antibody-dependent cellular cytotoxicity, release of inflammatory mediators and regulation of B cell activation. These functions are an important part of the mammalian response to infection, but if deployed inappropriately can cause autoimmune disease. Although most FcgammaRs are activatory, there is also an inhibitory FcgammaR that, when bound to IgG immune complexes, is able to downregulate the effects of both the activatory FcgammaRs and the B cell receptor. This review discusses the role of the low-affinity FcgammaRs in a balanced immune response and how perturbations in FcgammaR function result in susceptibility to infection or autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19674504     DOI: 10.1017/S1462399409001161

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  36 in total

1.  Evolution and immunity.

Authors:  Jim Kaufman
Journal:  Immunology       Date:  2010-05-11       Impact factor: 7.397

2.  Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.

Authors:  Jia Yao Phuah; Joshua T Mattila; Philana L Lin; JoAnne L Flynn
Journal:  Am J Pathol       Date:  2012-06-19       Impact factor: 4.307

3.  Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.

Authors:  Julien Ratelade; Nithi Asavapanumas; Alanna M Ritchie; Scott Wemlinger; Jeffrey L Bennett; A S Verkman
Journal:  Acta Neuropathol       Date:  2013-08-31       Impact factor: 17.088

4.  Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.

Authors:  Dhohyung Kim; Devra Huey; Michael Oglesbee; Stefan Niewiesk
Journal:  Blood       Date:  2011-02-28       Impact factor: 22.113

Review 5.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

6.  LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.

Authors:  Falk Nimmerjahn; Anja Lux
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-05       Impact factor: 11.205

Review 7.  Targeting B cells and autoantibodies in the therapy of autoimmune diseases.

Authors:  Daniela Kao; Anja Lux; Inessa Schwab; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

8.  Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity.

Authors:  Javid P Mohammed; Michael E Fusakio; Daniel B Rainbow; Carolyn Moule; Heather I Fraser; Jan Clark; John A Todd; Laurence B Peterson; Paul B Savage; Marsha Wills-Karp; William M Ridgway; Linda S Wicker; Jochen Mattner
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

9.  Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils.

Authors:  Louis Marois; Guillaume Paré; Myriam Vaillancourt; Emmanuelle Rollet-Labelle; Paul H Naccache
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

10.  Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.

Authors:  Cristina Fernandez-Arias; Jean Pierre Lopez; Jean Nikolae Hernandez-Perez; Maria Dolores Bautista-Ojeda; Oralee Branch; Ana Rodriguez
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.